🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT07539701
Starting soon Not applicable

An Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy

NCT07539701 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-03-23
Last updated
2026-04-20

Condition(s) studied

Lung Cancer (Diagnosis)Interstitial Lung Disease (ILD)

Investigational drug(s) / intervention(s)

Disposable Flexible Cryocatheter System

Disposable Flexible Cryocatheter System: The clinicaly required bronchosopic intervention requiring the use of a cryocatheter will be done with the Disposable Celsio Flexible Cryocatheter System

Study summary

This clinical trial is intended for patients awaiting an interventional bronchoscopy procedure where the use of a cryocatheter is considered. This type of catheter is already used in clinical practice for the treatment of certain types of bronchial obstructions, including tumors, granulomas, and for foreign bodies extractions. This catheter uses extremely cold temperatures offering unique advantages compared to heat-based technologies. Different types of reusable and single-use cryocatheters are actually available on the market. This type of device requires the use of expensive and bulky consoles operating with heavy gas tanks, resulting in high maintenance costs. A Quebec, Canada based company has developed a cryocatheter that combines procedural efficacy with practical considerations in mind. The Celsio cryocatheter operates without a console and is designed to accommodate the bronchscopist through the different types of cryogenic procedures.

This study aims to generate meaningful, real-world evidence without interfering with standard clinical care. The collected data will serve to characterize the device's performance profile, identify best practices for its use, and provide data for the design of future prospective comparative studies.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: \- Patient undergoing a bronchoscopic procedure with planned use of a 1.7mm cryocatheter Exclusion Criteria: * Patient undergoing a bronchoscopic procedure with planned use of a different size cryocatheter (eg 1.1 or 2.4mm) * Current pregnancy or lactation * Lack of free and informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institut universitaire de cardiologie et de pneumologie de Québec Québec Quebec

More Institut universitaire de cardiologie et de pneumologie de Québec, University Laval trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07539701 on ClinicalTrials.gov ↗ ← All trials in Canada